Is there a need for molecular genetic diagnosis of familial hypercholesterolaemia?;Er det behov for genteknologisk/cellebiologisk diagnostikk av familiær hyperkolesterolemi?

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 5, 1997, Pages 681-683

  Leren, Trond P ^a   Ose, Leiv ^b  

^a Avdeling for Medisinsk Genetikk   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

FEMALE; GENETIC PROCEDURES; GENETICS; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MALE; REVIEW;

FEMALE; GENETIC TECHNIQUES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; RECEPTORS, LDL;

EID: 0031579305     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Müller C. Angina pectoris in hereditary xanthomatosis. Arch Intern Med 1939; 64: 675-700.
2. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. I: Scriver CR, Baudet AL, Sly WS, Valle D, red. The metabolic basis of inherited disease, 7. utg. New York: McGraw-Hill, 1995: 1981-2030.
3. Slack J Risk of ischaemic heart disease in familial hyperlipoproteinaemic states. Lancet 1969, 2: 1380-2
4. Sugrue DD, Thompson GR, Oakley CM, Trayner IM, Steiner RE. Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia. BMJ 1981; 283: 1358-60.
5. Heiberg A, Berg K. The inheritance of hyperlipoproteinemia with xanthomatosis. A study of 132 kindreds. Clin Genet 1976; 9: 203-33.
6. Illingworth DR. Drug therapy of hypercholesterolemia. Clin Chem 1988; 34: 123-32.
7. Leren TP, Hjermann I, Berg K, Leren P, Foss OP, Viksmoen L. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Atherosclerosis 1988; 73: 135-41.
8. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
9. Williams RR, Hamilton-Craig I, Kostner GM, Hegele RA, Hayden MR, Pimstone SN et al. MED PED: An integrated genetic strategy for preventing early deaths. I: Berg K. Boulyjenkov V. Christen Y, red. Genetic approaches to non-communicable diseases. Berlin: Springer Verlag-Berlin, 1996: 35-46.
10. Ose L, Tonstad S, Vesterhus P, Wefring KW. Diagnose og behandling av familiær hyperkolesterolemi hos barn og ungdom. Tidsskr Nor Lægeforen 1995; 115: 3499-503.
11. Study Group, European Atherosclerosis Society. The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart J 1988; 9: 571-600.
12. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544-68.
13. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 1989; 86: 587-91.
14. Kwiterovich PO, Fredrickson DS, Levy RI. Familial hypercholesterolemi (one form of familial type II hyperlipoproteinemia). J Clin Invest 1974; 53: 1237-49.
15. Schrott HG, Goldstein JL, Hazzard WR, McGoodwin MM, Motulsky AG. Familial hypercholesterolemia in a large kindred. Evidence for a monogenic mechanism. Ann Intern Med 1972; 76: 711-20.
16. Løhne K, Urdal P, Leren TP, Tonstad S, Ose L. Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells. Cytometry 1995; 20: 290-5.
17. Lewis B. The hyperlipoproteinemias - clinical and laboratory practice. Oxford: Blackwell Scientific Publications, 1976.
18. Bild DE, Williams RR, Brewer HB, Herd JA, Pearson TA, Stein E. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop. Am J Cardiol 1993; 72: 1D-5D.
19. Wirebaugh SR, Whitney EJ. Long-term compliance with lipid-lowering therapy. P&T 1993; 18: 559-71.
20. Leren TP, Tonstad S, Bakken KS, Rødningen OK, Gundersen KE, Sundvold H et al. Genteknologisk diagnostikk av familiær hyperkolesterolemi. Tidsskr Nor Lægeforen 1997; 117: 678-81.
21. Leren TP, Tonstad S, Gundersen KE, Bakken KS, Rødningen OK, Sundvold H et al. Molecular genetics of familial hypercholesterolemia in Norway. J Int Med. Akseptert for publisering.